{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:21:49Z","timestamp":1792747309311,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015459","name":"Danish Cancer Society Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.radonc.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T12:42:21Z","timestamp":1597408941000},"page":"126-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224)"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6973-3550","authenticated-orcid":false,"given":"Mette","family":"Saks\u00f8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Saks\u00f8","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Primdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Kallehauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian R\u00f8nn","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2020.08.006_b0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2012.171","article-title":"Imaging hypoxia to improve radiotherapy outcome","volume":"9","author":"Horsman","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2012.09.015","article-title":"FAZA PET\/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial","volume":"105","author":"Mortensen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2014.11.032","article-title":"Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer","volume":"113","author":"Lassen","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0020","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3109\/0284186X.2015.1074720","article-title":"Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure","volume":"54","author":"Zschaeck","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0025","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/0284186X.2017.1372626","article-title":"Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer","volume":"56","author":"Boeke","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2017.09.019","article-title":"Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy","volume":"126","author":"Hansen","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0035","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1080\/0284186X.2019.1658897","article-title":"A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma","volume":"58","author":"Saks\u00f8","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1120\/jacmp.v17i3.5735","article-title":"Benchmarking of five commercial deformable image registration algorithms for head and neck patients","volume":"17","author":"Pukala","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2020.08.006_b0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.radonc.2012.09.017","article-title":"Scoring and classification of oropharyngeal carcinoma based on HPV-related p16-expression","volume":"105","author":"Lassen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2011.09.010","article-title":"Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck","volume":"102","author":"Toustrup","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0055","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3109\/0284186X.2015.1063780","article-title":"Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial","volume":"54","author":"Hansen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.radonc.2018.02.018","article-title":"DAHANCA 10 \u2013 Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group","volume":"127","author":"Overgaard","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0065","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1080\/0284186X.2019.1629015","article-title":"Distinguishing recurrence and new primary tumor as well as the origin of neck metastases in head and neck cancer clinical trials by targeted DNA sequencing","volume":"58","author":"Lilja-Fischer","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00066-012-0127-y","article-title":"Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma","volume":"188","author":"Due","year":"2012","journal-title":"Strahlentherapie und Onkol"},{"key":"10.1016\/j.radonc.2020.08.006_b0075","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1080\/0284186X.2017.1346384","article-title":"Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods","volume":"56","author":"Zukauskaite","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2017.10.018","article-title":"Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project","volume":"126","author":"Lassen","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0085","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.radonc.2016.11.008","article-title":"HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation","volume":"121","author":"Linge","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2012.01.011","article-title":"Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma \u2013 A prospective study","volume":"103","author":"Hoff","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.radonc.2017.10.007","article-title":"Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy","volume":"126","author":"Ou","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.radonc.2018.09.008","article-title":"FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients","volume":"130","author":"Bandurska-Luque","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0105","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.radonc.2014.06.001","article-title":"Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake","volume":"111","author":"Due","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0110","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ijrobp.2015.12.380","article-title":"Elective Nodal Irradiation and Patterns of Failure in Head and Neck Cancer After Primary Radiation Therapy","volume":"94","author":"Kjems","year":"2016","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2020.08.006_b0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2017.11.024","article-title":"Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins","volume":"126","author":"Zukauskaite","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2017.04.015","article-title":"Inadequate target volume delineation and local\u2013regional recurrence after intensity-modulated radiotherapy for human papillomavirus-positive oropharynx cancer","volume":"123","author":"Chen","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2019.02.020","article-title":"Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy","volume":"135","author":"L\u00f6ck","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0130","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1088\/0031-9155\/61\/22\/7957","article-title":"Quantifying hypoxia in human cancers using static PET imaging","volume":"61","author":"Taylor","year":"2016","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2020.08.006_b0135","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3109\/0284186X.2015.1071496","article-title":"Robustness of quantitative hypoxia PET image analysis for predicting local tumor control","volume":"54","author":"M\u00f6nnich","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2020.05.022","article-title":"Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy","volume":"149","author":"Zschaeck","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2012.08.019","article-title":"Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer","volume":"105","author":"Zips","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0150","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00259-014-2730-x","article-title":"A prospective clinical study of 18F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy","volume":"41","author":"Servagi-Vernat","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2020.08.006_b0155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.radonc.2017.08.010","article-title":"Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging","volume":"124","author":"L\u00f6ck","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0160","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.radonc.2017.04.004","article-title":"Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial","volume":"124","author":"Welz","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13014-017-0776-1","article-title":"Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours?","volume":"12","author":"Pigorsch","year":"2017","journal-title":"The ESCALOX protocol. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2020.08.006_b0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2016.03.005","article-title":"Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer","volume":"120","author":"Rasmussen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/0284186X.2017.1364867","article-title":"Late mucosal ulcers in dose-escalated adaptive dose-painting treatments for head-and-neck cancer","volume":"57","author":"Olteanu","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.radonc.2020.03.025","volume":"148","author":"Saks\u00f8","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0185","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/0284186X.2019.1695065","article-title":"DAHANCA 33: functional image-guided dose-escalated radiotherapy to patients with hypoxic squamous cell carcinoma of the head and neck (NCT02976051)","volume":"59","author":"Saks\u00f8","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.08.006_b0190","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/hed.24892","article-title":"Long-term outcome of 18F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study","volume":"39","author":"Berwouts","year":"2017","journal-title":"Head Neck"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020307246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020307246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:12:06Z","timestamp":1759122726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814020307246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":38,"alternative-id":["S0167814020307246"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2020.08.006","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224)","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}